AN1
Click for more information
0.00% 0.8¢ anagenics limited

Lyramid is engaged in the research and development of treatments...

  1. Pharmargeddon
    3,152 Posts.
    lightbulb Created with Sketch. 335
    clock Created with Sketch.
    13/11/20
    06:57
    Post #: 48842634
    Lyramid is engaged in the research and development of treatments for inflammatory diseases and cancer
    targeting midkine, an embryonic growth factor implicated in a number of disease indications. The Company
    owns a number of patents     pertaining to the use of antibodies against midkine for the treatment of these
    conditions. Lyramid holds an exclusive license in relation to these patents.

    Rinse and repeat
    CDY Price at posting: 10.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS What matters for FY25: Investment; interest rates; inflation & elections
right-arrow Created with Sketch.
SKS SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
right-arrow Created with Sketch.
I88 Infini Resources announces exceptionally high-grade uranium soil assay results
right-arrow Created with Sketch.
GED Golden Deeps eyes prospective Cu-Au tenements in NSW with HOA
right-arrow Created with Sketch.
NEWS Buying smarter as baby boomers get boost
right-arrow Created with Sketch.
TX3 Canadian fieldwork yields multiple pegmatites for Trinex
right-arrow Created with Sketch.
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
(20min delay)
Last
0.8¢ 		Change
0.000(0.00%) 		Mkt cap ! $3.690M
Open High Low Value Volume
0.8¢ 0.8¢ 0.8¢ $336 42K

Buyers (Bids)

No. Vol. Price($)
3 1457234 0.8¢
 

Sellers (Offers)

Price($) Vol. No.
0.9¢ 340000 1
View Market Depth
Last trade - 14.19pm 12/07/2024 (20 minute delay) ?
AN1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.